{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:57:39Z","timestamp":1789761459076,"version":"4.0.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2014,5,13]]},"DOI":"10.1161\/circulationaha.114.009584","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T06:17:49Z","timestamp":1395123469000},"page":"1905-1908","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["A New START for Sildenafil in Pediatric Pulmonary Hypertension"],"prefix":"10.1161","volume":"129","author":[{"given":"Doff B.","family":"McElhinney","sequence":"first","affiliation":[{"name":"From the NYU School of Medicine, Departments of Pediatrics, Cardiothoracic Surgery, and Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050010"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.031"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.026591"},{"key":"e_1_3_2_5_2","unstructured":"US Food and Drug Administration. FDA Drug Safety Communication: FDA recommends against use of Revatio (sildenafil) in children with pulmonary hypertension. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm317123.htm. Accessed February 24 2014."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201301-0159LE"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-303981"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201210-1928PP"},{"key":"e_1_3_2_9_2","unstructured":"Hayashi N Harnisch L. Population PK of sildenafil and PK\/PD assessment of exercise tolerability in children with pulmonary arterial hypertension (PAH). PAGE 18. 2009. Abstract 1523. [www.page-meeting.org\/?abstract=1523]. Accessed February 24 2014."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-12-54"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005698"},{"key":"e_1_3_2_12_2","unstructured":"Watt S Hayashi N Harnish L Gao X. Population pharmacokinetics (PK) of sildenafil in paediatric and adult patients with pulmonary arterial hypertension (PAH). Paper presented at: European Society of Cardiology Annual Meeting; August 28\u2013September 1 2010; Stockholm Sweden."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.2.9906015"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.4103\/2045-8932.109931"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2012.07.019"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.108886"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.13-230714"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.4103\/2045-8932.109933"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2008.10.003"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/0883073813495959"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7133.2012.00293.x"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.114.009584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T06:45:35Z","timestamp":1715582735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.114.009584"}},"subtitle":["Reframing the Dose\u2013Survival Relationship in the STARTS-2 Trial"],"short-title":[],"issued":{"date-parts":[[2014,5,13]]},"references-count":20,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2014,5,13]]}},"alternative-id":["10.1161\/CIRCULATIONAHA.114.009584"],"URL":"https:\/\/doi.org\/10.1161\/circulationaha.114.009584","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,13]]},"assertion":[{"value":"2014-03-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}